2013China Practical MedicineRequires access

Clinical study of Amiodarone and irbesartan on the treatment of paroxysmal atrial fibrillation

Wenhu Li

Open publisher page 0 citations

Abstract

Objective To observe the effect of combination of amiodarone and Renin-Angiotensin System(RAS) inhibitors irbesartan maintenance of sinus rhythm after cardioversion in patients with paroxysmal atrial fibrillation and its influence on left atrial function.Methods 146 patients with paroxysmal AF were randomly divided into two groups:amiodarone group(n=72) and amiodarone plus Irbesartan group(n=74).The duration of observation was up to 12 months.Results After the treatment and 12 month follow-up,There was no statistically significant difference in the left atrial diameter(LAD) between Group I and Group II in the 1 st and the 3rd month.But there was significant difference(P0.05) in maintenance rate of sinus rhythm and left atrial diameter in the 6th and the 12th month.Conclusion The combination of amiodarone and irbesartan is more effective than amiodarone alone for sinus rhythm maintenance,and can restrain the enlargement of the left atrium.

About this research paper

What this paper is about

Objective To observe the effect of combination of amiodarone and Renin-Angiotensin System(RAS) inhibitors irbesartan maintenance of sinus rhythm after cardioversion in patients with paroxysmal atrial fibrillation and its influence on left atrial function.Methods 146 patients with paroxysmal AF were randomly divided into two groups:amiodarone group(n=72) and amiodarone plus Irbesartan group(n=74).The duration of observation was up to 12 months.Results After the treatment and 12 month follow-up,There was no statistically significant difference in the left atrial diameter(LAD) between Group I and Group II in the 1 st and the 3rd month.But there was significant difference(P0.05) in maintenance rate of sinus rhythm and left atrial diameter in the 6th and the 12th month.Conclusion The combination of amiodarone and irbesartan is more effective than amiodarone alone for sinus rhythm maintenance,and can restrain the enlargement of the left atrium.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect of combination of amiodarone and Renin-Angiotensin System(RAS) inhibitors irbesartan maintenance of sinus rhythm after cardioversion in patients with paroxysmal atrial fibrillation and its influence on left atrial function.Methods 146 patients with paroxysmal AF were randomly divided into two groups:amiodarone group(n=72) and amiodarone plus Irbesartan group(n=74).The duration of observation was up to 12 months.Results After the treatment and 12 month follow-up,There was no statistically significant difference in the left atrial diameter(LAD) between Group I and Group II in the 1 st and the 3rd month.But there was significant difference(P0.05) in maintenance rate of sinus rhythm and left atrial diameter in the 6th and the 12th month.Conclusion The combination of amiodarone and irbesartan is more effective than amiodarone alone for sinus rhythm maintenance,and can restrain the enlargement of the left atrium.

Key concepts: Medicine, Amiodarone, Irbesartan, Sinus rhythm, Cardiology, Internal medicine, Atrial fibrillation, Paroxysmal atrial fibrillation

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical study of Amiodarone and irbesartan on the treatment of paroxysmal atrial fibrillation — Research Paper | ScholarLens